<p>Methods for activating HCV-specific T cells are described. The methods utilize one or more administrations of HCV protein compositions, followed by one or more administrations of a viral vector comprising a nucleic acid encoding a least one HCV epitope that is present in the first composition. The protein compositions can further comprise an immunostimulatory nucleic acid and or other adjuvants and immune stimulatory compounds.</p>
申请公布号
WO2007081848(A3)
申请公布日期
2007.11.15
申请号
WO2007US00362
申请日期
2007.01.04
申请人
NOVARTIS VACCINES AND DIAGNOSTICS, INC.;HOUGHTON, MICHAEL;LIN, YIN-LING